$5.89
Today
as of Jul 22, 16:25 ET
Last 30 days
Recent Press Releases & News
RBC Capital Reaffirms Outperform Rating For Verastem (VSTM)
Verastem (VSTM) Surges 6.3%: Is This an Indication of Further Gains?
RBC Capital Adjusts Verastem Price Target to $14 From $15, Maintains Outperform Rating
Overview
52-week range
$3.58
$11
30% of range
Avg surprise (last 3)
+0.2%
Avg reaction (last 2)
-1.7%
50% positive
Latest IV / EM
109%
EM ±25.4% · $6 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.46 | $-0.46 | 0.0% | +52.1% | -5.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.35 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.39 | $-0.59 | +33.9% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.96 | $-0.72 | -33.3% | — | +2.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.60 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.31 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.26 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.75 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.37 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | -$0.46 | -$0.39 | -17.9% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | — | $11M | $2M | — | — | — | $10M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-45M | — | $-41M | $-44M | $-44M | — | $-37M | $-18M |
| Net income | $-37M | — | $-99M | $-26M | $-52M | — | $-24M | $-8M |
| EPS (diluted) | $-0.46 | — | $-1.35 | $-0.62 | $-0.96 | — | $-0.60 | $-0.31 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $166M | $205M | $138M | $164M | $118M | $89M | $113M | $83M |
| Inventory | $2M | $2M | $2M | $1M | — | — | — | — |
| Total current assets | $203M | $223M | $154M | $174M | $125M | $95M | $121M | $100M |
| Total assets | $228M | $246M | $177M | $196M | $132M | $102M | $126M | $106M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $146M | $189M | $192M | $160M | $164M | $130M | $94M | $66M |
| Total equity | $82M | $57M | $-16M | $36M | $-32M | $-29M | $11M | $19M |